{"id":"https://openalex.org/A5000627837","orcid":null,"observed_orcids":[],"display_name":"Bj\u00f6rn Glinghammar","raw_author_names":["B Glinghammar","B. Glinghammar","BJ\u00d6RN GLINGHAMMAR","Bjorn Glinghammar","Bj\u00f6rn Glinghammar"],"full_name":"BJ\u00d6RN GLINGHAMMAR","works_count":34,"cited_by_count":1449,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":22,"i10_index":24},"ids":{"openalex":"https://openalex.org/A5000627837","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I1335113835","ror":"https://ror.org/00m8d6786","display_name":"Karolinska University Hospital","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},"years":[2003]},{"institution":{"id":"https://openalex.org/I2800139495","ror":"https://ror.org/04ev03g22","display_name":"Science for Life Laboratory","country_code":"SE","type":"facility","lineage":["https://openalex.org/I2800139495"]},"years":[2022,2020]},{"institution":{"id":"https://openalex.org/I2800664555","ror":"https://ror.org/03nnxqz81","display_name":"RISE Research Institutes of Sweden","country_code":"SE","type":"other","lineage":["https://openalex.org/I2800664555"]},"years":[2023]},{"institution":{"id":"https://openalex.org/I28166907","ror":"https://ror.org/056d84691","display_name":"Karolinska Institutet","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},"years":[2022,2020,2016,2003,2002,2001,1999,1998,1997]},{"institution":{"id":"https://openalex.org/I4210128105","ror":"https://ror.org/0376t7t08","display_name":"S\u00f6dert\u00e4lje Sjukhus","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210128105"]},"years":[2008]},{"institution":{"id":"https://openalex.org/I4210137624","ror":"https://ror.org/04asvbz37","display_name":"Swedish Orphan Biovitrum (Sweden)","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210137624"]},"years":[2023]},{"institution":{"id":"https://openalex.org/I4210143795","ror":"https://ror.org/04wwrrg31","display_name":"AstraZeneca (Sweden)","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]},"years":[2016,2015,2014,2013,2012,2011,2009,2008,2007]}],"last_known_institutions":[{"id":"https://openalex.org/I2800664555","ror":"https://ror.org/03nnxqz81","display_name":"RISE Research Institutes of Sweden","country_code":"SE","type":"other","lineage":["https://openalex.org/I2800664555"]},{"id":"https://openalex.org/I4210137624","ror":"https://ror.org/04asvbz37","display_name":"Swedish Orphan Biovitrum (Sweden)","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210137624"]}],"topics":[{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","count":14,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","count":8,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","count":6,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","count":5,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10433","display_name":"Carcinogens and Genotoxicity Assessment","count":5,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","value":9.23e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","value":6.22e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13984","display_name":"Nutrition, Genetics, and Disease","value":5.17e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12975","display_name":"Paraoxonase enzyme and polymorphisms","value":2.96e-05,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","value":2.86e-05,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.7807562351226807},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.66800457239151},{"id":"104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","score":0.6035010814666748},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.5922790765762329},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.4243052899837494}],"counts_by_year":[{"year":1997,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":1998,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":1999,"works_count":3,"oa_works_count":0,"cited_by_count":0},{"year":2000,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2001,"works_count":2,"oa_works_count":1,"cited_by_count":0},{"year":2002,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":2003,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":2006,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2007,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":2008,"works_count":2,"oa_works_count":1,"cited_by_count":0},{"year":2009,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2011,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2012,"works_count":4,"oa_works_count":1,"cited_by_count":42},{"year":2013,"works_count":1,"oa_works_count":0,"cited_by_count":51},{"year":2014,"works_count":1,"oa_works_count":0,"cited_by_count":51},{"year":2015,"works_count":1,"oa_works_count":0,"cited_by_count":79},{"year":2016,"works_count":2,"oa_works_count":1,"cited_by_count":66},{"year":2017,"works_count":0,"oa_works_count":0,"cited_by_count":51},{"year":2018,"works_count":0,"oa_works_count":0,"cited_by_count":66},{"year":2019,"works_count":0,"oa_works_count":0,"cited_by_count":45},{"year":2020,"works_count":1,"oa_works_count":1,"cited_by_count":48},{"year":2021,"works_count":0,"oa_works_count":0,"cited_by_count":48},{"year":2022,"works_count":2,"oa_works_count":2,"cited_by_count":46},{"year":2023,"works_count":3,"oa_works_count":3,"cited_by_count":60},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":93},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":113},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":95}],"display_name_alternatives":["B Glinghammar","B. Glinghammar","BJ\u00d6RN GLINGHAMMAR","Bjorn Glinghammar","Bj\u00f6rn Glinghammar"],"block_key":"b glinghammar","works_api_url":"https://api.openalex.org/works?filter=author.id:A5000627837","updated_date":"2026-11-04T11:47:51","created_date":"2016-06-24T00:00:00"}